Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,310 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prospective study of methotrexate treatment for rheumatoid arthritis treated legitimately according to the government recommended 8 mg/week dose.
Hashiramoto A, Shiozawa K, Tanaka Y, Yamane T, Murata M, Tanaka C, Terashima Y, Koyama K, Nakagawa N, Abe S, Yoshihara R, Saegusa Y, Tsumiyama K, Komai K, Sakai Y, Shiozawa S. Hashiramoto A, et al. Among authors: tanaka c, tanaka y. Mod Rheumatol. 2009;19(6):637-42. doi: 10.1007/s10165-009-0205-x. Epub 2009 Jul 22. Mod Rheumatol. 2009. PMID: 19626390
[Susceptibility genes in rheumatoid arthritis: mutation in DR3 gene].
Shiozawa S, Hashiramoto A, Osawa K, Takami N, Miura Y, Kurosaka M, Yoshiya S, Koyama K, Terashima Y, Abe S, Nakagawa N, Saegusa Y, Tanaka Y, Shiozawa K, Iguchi T. Shiozawa S, et al. Among authors: tanaka y. Nihon Rinsho. 2005 Jan;63 Suppl 1:122-6. Nihon Rinsho. 2005. PMID: 15799330 Review. Japanese. No abstract available.
Clinical activity after 12 weeks of treatment with nonbiologics in early rheumatoid arthritis may predict articular destruction 2 years later.
Ichikawa Y, Saito T, Yamanaka H, Akizuki M, Kondo H, Kobayashi S, Oshima H, Kawai S, Hama N, Yamada H, Mimori T, Amano K, Tanaka Y, Matsuoka Y, Yamamoto S, Matsubara T, Murata N, Asai T, Suzuki Y; Study Group for the Japanese Ministry of Health, Labor and Welfare, Research for Establishment of Therapeutic Guidelines in Early Rheumatoid Arthritis Program. Ichikawa Y, et al. Among authors: tanaka y. J Rheumatol. 2010 Apr;37(4):723-9. doi: 10.3899/jrheum.090776. Epub 2010 Mar 1. J Rheumatol. 2010. PMID: 20194455 Clinical Trial.
Therapeutic effects of the combination of methotrexate and bucillamine in early rheumatoid arthritis: a multicenter, double-blind, randomized controlled study.
Ichikawa Y, Saito T, Yamanaka H, Akizuki M, Kondo H, Kobayashi S, Oshima H, Kawai S, Hama N, Yamada H, Mimori T, Amano K, Tanaka Y, Matsuoka Y, Yamamoto S, Matsubara T, Murata N, Asai T, Suzuki Y; MTX-BUC Combination Study Group; Japanese Ministry of Health; Labour and Welfare's "Research for Establishment of Therapeutic Guidelines in Early Rheumatoid Arthritis". Ichikawa Y, et al. Among authors: tanaka y. Mod Rheumatol. 2005;15(5):323-8. doi: 10.1007/s10165-005-0420-z. Mod Rheumatol. 2005. PMID: 17029087
Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to at least one tumor necrosis factor inhibitor: results of a forty-eight–week randomized, double-blind, placebo-controlled, parallel-group phase III trial.
Tak PP, Mease PJ, Genovese MC, Kremer J, Haraoui B, Tanaka Y, Bingham CO 3rd, Ashrafzadeh A, Travers H, Safa-Leathers S, Kumar S, Dummer W. Tak PP, et al. Among authors: tanaka y. Arthritis Rheum. 2012 Feb;64(2):360-70. doi: 10.1002/art.33353. Arthritis Rheum. 2012. PMID: 22389919 Free article. Clinical Trial.
15,310 results
You have reached the last available page of results. Please see the User Guide for more information.